Horinouchi Hiroki
Department of Radiology, National Cerebral and Cardiovascular Center, Japan.
Interv Radiol (Higashimatsuyama). 2025 Apr 25;10:e20240040. doi: 10.22575/interventionalradiology.2024-0040. eCollection 2025.
Type II endoleak is the most common complication after endovascular abdominal aortic aneurysm repair. Type II endoleak with aneurysm sac growth is not benign for long-term outcomes of endovascular abdominal aortic aneurysm repair and should be treated to prevent secondary stent graft-related complications and aneurysm rupture. The current consensus is to consider treatments for persistent type II endoleak with significant aneurysm sac growth. For complete embolization of type II endoleak to obliterate the endoleak cavity with the elimination of all supplying arteries, it is necessary to select and combine the treatment options. Although the treatment techniques for type II endoleak have advanced, clinical outcomes remain unsatisfactory. To overcome this clinical discrepancy, the optimal patient-tailored treatment strategy is required in clinical practice, with an understanding of the current status and limitations of treatment for type II endoleak.
II型内漏是腹主动脉瘤腔内修复术后最常见的并发症。伴有瘤腔增大的II型内漏对腹主动脉瘤腔内修复术的长期预后并非良性,应进行治疗以预防与支架移植物相关的继发性并发症和动脉瘤破裂。目前的共识是,对于伴有明显瘤腔增大的持续性II型内漏应考虑进行治疗。为了完全栓塞II型内漏以闭塞内漏腔并消除所有供血动脉,有必要选择并联合治疗方案。尽管II型内漏的治疗技术已有进展,但临床疗效仍不尽人意。为克服这一临床差异,临床实践中需要根据患者情况制定最佳治疗策略,同时了解II型内漏治疗的现状和局限性。